
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Heavy metals: toxicity and human health effects
Klaudia Jomová, Suliman Yousef Alomar, Eugenie Nepovimová, et al.
Archives of Toxicology (2024)
Open Access | Times Cited: 24
Klaudia Jomová, Suliman Yousef Alomar, Eugenie Nepovimová, et al.
Archives of Toxicology (2024)
Open Access | Times Cited: 24
Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
Maroua Jalouli, Md. Ataur Rahman, Partha Biswas, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 3
Maroua Jalouli, Md. Ataur Rahman, Partha Biswas, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 3
Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer’s Disease Pathogenesis—From Gut Microbiota and Viruses to Brain Biofilms
Anna Onisiforou, Eleftheria G. Charalambous, Panos Zanos
Microorganisms (2025) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 2
Anna Onisiforou, Eleftheria G. Charalambous, Panos Zanos
Microorganisms (2025) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 2
The Alteration of Microglial Calcium Homeostasis in Central Nervous System Disorders: A Comprehensive Review
ATM Hasibul Hasan, Faria Tasnim, Md. Aktaruzzaman, et al.
Neuroglia (2024) Vol. 5, Iss. 4, pp. 410-444
Open Access | Times Cited: 9
ATM Hasibul Hasan, Faria Tasnim, Md. Aktaruzzaman, et al.
Neuroglia (2024) Vol. 5, Iss. 4, pp. 410-444
Open Access | Times Cited: 9
Role of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1462-1462
Open Access | Times Cited: 8
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1462-1462
Open Access | Times Cited: 8
Relationship between enriched environment and neurodegeneration: a review from mechanism to therapy
Yang Xu, YangQuan Chen, Jia‐xin Xing, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Yang Xu, YangQuan Chen, Jia‐xin Xing, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease
Mona Abdelhamid, Scott Counts, Chunyu Zhou, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 558-558
Open Access | Times Cited: 1
Mona Abdelhamid, Scott Counts, Chunyu Zhou, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 558-558
Open Access | Times Cited: 1
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access | Times Cited: 1
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025) Vol. 569, pp. 161-183
Closed Access | Times Cited: 1
Tyrosine kinase as therapeutic target of neurodegenerative disorders
Dipanjan Karati, Dileep Kumar
Brain Disorders (2025), pp. 100193-100193
Open Access | Times Cited: 1
Dipanjan Karati, Dileep Kumar
Brain Disorders (2025), pp. 100193-100193
Open Access | Times Cited: 1
Modulation of the Neuro–Cancer Connection by Metabolites of Gut Microbiota
Alice Njolke Mafe, Dietrich Büsselberg
Biomolecules (2025) Vol. 15, Iss. 2, pp. 270-270
Open Access | Times Cited: 1
Alice Njolke Mafe, Dietrich Büsselberg
Biomolecules (2025) Vol. 15, Iss. 2, pp. 270-270
Open Access | Times Cited: 1
Limonin (LM) and its derivatives: Unveiling the neuroprotective and anti-inflammatory potential of LM and V-A-4 in the management of Alzheimer's disease and Parkinson's disease
Siva Prasad Panda, Adarsh Kesharwani, Mansi Singh, et al.
Fitoterapia (2024) Vol. 178, pp. 106173-106173
Closed Access | Times Cited: 7
Siva Prasad Panda, Adarsh Kesharwani, Mansi Singh, et al.
Fitoterapia (2024) Vol. 178, pp. 106173-106173
Closed Access | Times Cited: 7
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis
Styliani Theophanous, Irene Sargiannidou, Kleopas A. Kleopa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9588-9588
Open Access | Times Cited: 7
Styliani Theophanous, Irene Sargiannidou, Kleopas A. Kleopa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9588-9588
Open Access | Times Cited: 7
Advancing the understanding of diabetic encephalopathy through unravelling pathogenesis and exploring future treatment perspectives
Aarti Nagayach, Rakesh Bhaskar, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102450-102450
Closed Access | Times Cited: 6
Aarti Nagayach, Rakesh Bhaskar, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102450-102450
Closed Access | Times Cited: 6
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies
Jameel M. Al-Khayri, Mithunan Ravindran, Akshatha Banadka, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1391-1391
Open Access | Times Cited: 6
Jameel M. Al-Khayri, Mithunan Ravindran, Akshatha Banadka, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1391-1391
Open Access | Times Cited: 6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6
The Importance of Phosphoinositide 3-Kinase in Neuroinflammation
Bradley J. Wright, Samuel King, Cenk Suphioglu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11638-11638
Open Access | Times Cited: 6
Bradley J. Wright, Samuel King, Cenk Suphioglu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11638-11638
Open Access | Times Cited: 6
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access
Gold nanoparticles “AuNPs” -mediated amelioration of experimentally toxic-induced cerebellar syndrome: Insights into cytomolecular and immuno-histochemical modifications, with a focus on CREB/ Tau modulation
Mai A. Samak, yara elfakharany, Nancy Huessiny, et al.
Tissue and Cell (2025) Vol. 93, pp. 102725-102725
Closed Access
Mai A. Samak, yara elfakharany, Nancy Huessiny, et al.
Tissue and Cell (2025) Vol. 93, pp. 102725-102725
Closed Access
Aberrant expression of long noncoding RNAs regulates inflammasome activation via oxidative stress: A novel mechanism for neuroinflammation and neurodegeneration in Parkinson's disease
Irene Mary Praveen, Calivarathan Latchoumycandane
Clinical and Experimental Neuroimmunology (2025)
Closed Access
Irene Mary Praveen, Calivarathan Latchoumycandane
Clinical and Experimental Neuroimmunology (2025)
Closed Access
Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model
Yu‐Zhong Zhang, Shuai Lv, Pei-Zheng Huang, et al.
npj Science of Food (2025) Vol. 9, Iss. 1
Open Access
Yu‐Zhong Zhang, Shuai Lv, Pei-Zheng Huang, et al.
npj Science of Food (2025) Vol. 9, Iss. 1
Open Access
Meroterpenoids from Terrestrial and Marine Fungi: Promising Agents for Neurodegenerative Disorders—An Updated Review
Daniela S. Dimitrova, Simeonka Dimitrova, Gabriela Kehayova, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 96-96
Open Access
Daniela S. Dimitrova, Simeonka Dimitrova, Gabriela Kehayova, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 96-96
Open Access
Traditionally Used Edible Flowers as a Source of Neuroactive, Antioxidant, and Anti-Inflammatory Extracts and Bioactive Compounds: A Narrative Review
Maciej Książkiewicz, Michalina Karczewska, Filip Nawrot, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 677-677
Open Access
Maciej Książkiewicz, Michalina Karczewska, Filip Nawrot, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 677-677
Open Access
The role of the gut microbiome in Alzheimer's disease pathophysiology
Alejandro Borrego-Ruiz, Juan J. Borrego
Current Opinion in Neurology (2025)
Closed Access
Alejandro Borrego-Ruiz, Juan J. Borrego
Current Opinion in Neurology (2025)
Closed Access
Microbial signatures and therapeutic strategies in neurodegenerative diseases
Mlaak Rob, Mahmoud Yousef, Arun Prasath Lakshmanan, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117905-117905
Open Access
Mlaak Rob, Mahmoud Yousef, Arun Prasath Lakshmanan, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117905-117905
Open Access
Therapeutic Potential and Challenges of Pioglitazone in Cancer Treatment
Maria Vasileiou, Sotirios Charalampos Diamantoudis, Christina Tsianava, et al.
Applied Sciences (2025) Vol. 15, Iss. 4, pp. 1925-1925
Open Access
Maria Vasileiou, Sotirios Charalampos Diamantoudis, Christina Tsianava, et al.
Applied Sciences (2025) Vol. 15, Iss. 4, pp. 1925-1925
Open Access